• About us
• Contact

Advertisement

Person › Details

Nicholas Adomakah (Sandoz (division of Novartis))

Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead)

 

	Organisation	Sandoz (division of Novartis)
	Group	Novartis (Group)
	Product	anti-infective drug
	Product 2	DRUGS, GENERICS

Record changed: 2023-01-24

Advertisement

More documents for Nicholas Adomakah

• [1] Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.